New research in mice shows that two commonly used gout medications, which target uric acid and adenosine triphosphate, may offer protection from alcohol-induced liver disease and inflammation. These findings suggest that clinical trials in humans with alcoholic liver disease should be considered. The report appears in the August 2015 issue of the Journal of Leukocyte Biology.
↧